Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fluor (FLR) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Fluor (FLR) over the last 17 years, with Q4 2025 value amounting to $2.1 billion.

  • Fluor's Cash & Equivalents fell 2453.16% to $2.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.1 billion, marking a year-over-year decrease of 2453.16%. This contributed to the annual value of $2.1 billion for FY2025, which is 2453.16% down from last year.
  • According to the latest figures from Q4 2025, Fluor's Cash & Equivalents is $2.1 billion, which was down 2453.16% from $2.8 billion recorded in Q3 2025.
  • Over the past 5 years, Fluor's Cash & Equivalents peaked at $2.9 billion during Q3 2024, and registered a low of $1.9 billion during Q1 2022.
  • For the 5-year period, Fluor's Cash & Equivalents averaged around $2.4 billion, with its median value being $2.4 billion (2023).
  • Its Cash & Equivalents has fluctuated over the past 5 years, first skyrocketed by 3764.85% in 2021, then plummeted by 2453.16% in 2025.
  • Quarter analysis of 5 years shows Fluor's Cash & Equivalents stood at $2.2 billion in 2021, then grew by 10.41% to $2.4 billion in 2022, then increased by 3.28% to $2.5 billion in 2023, then increased by 12.31% to $2.8 billion in 2024, then fell by 24.53% to $2.1 billion in 2025.
  • Its Cash & Equivalents was $2.1 billion in Q4 2025, compared to $2.8 billion in Q3 2025 and $2.2 billion in Q2 2025.